Supernus Pharmaceuticals
SUPN
#4436
Rank
C$2.37 B
Marketcap
$42.60
Share price
0.16%
Change (1 day)
7.16%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2024 (TTM): C$0.13 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are C$0.66 Billion. , an increase over its 2023 earnings that were of C$7.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 C$0.13 B1787.92%
2023 C$7.17 M-92.36%
2022 C$93.9 M-29.8%
2021 C$0.13 B-49.79%
2020 C$0.26 B12.99%
2019 C$0.23 B7.58%
2018 C$0.21 B54.9%
2017 C$0.14 B84.25%
2016 C$76.8 M202.27%
2015 C$25.4 M-462.04%
2014 -C$7.02 Million-94%
2013 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.3 Billion-316.65%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.19 B 1,516.33%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.55 B 12,856.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$11.61 Billion-8,661.36%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.71 B 7,065.63%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.15 B 17,721.60%๐Ÿ‡บ๐Ÿ‡ธ USA